Synopsis
0
CEP/COS
0
EU WC
0
KDMF
0
VMF
0
EDQM
0
USP
0
JP
0
Others
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
API
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
API SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
USDMF
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Related Excipient Companies
SPI Pharma
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Faran Shimi Pharmaceutical
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Gangwal Healthcare
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Anhui Sunhere Pharmaceutical Excipients Co.,Ltd
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Gangwal Chemicals
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Ingredion Pharma Solutions
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Kerry
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Microlex e.U
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Pluviaendo
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Prachin Chemical
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Roquette
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Seppic
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Shanghai Shenmei Pharmaceutical Technology Co., Ltd
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Sigachi Industries
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Fillers, Diluents & Binders
Lubricants & Glidants
Direct Compression
Granulation
Taste Masking
Co-Processed Excipients
Coating Systems & Additives
Emulsifying Agents
Thickeners and Stabilizers
Controlled & Modified Release
Chewable & Orodispersible Aids
Disintegrants & Superdisintegrants
API Stability Enhancers
Topical
Surfactant & Foaming Agents
Digital Content
NEWS #PharmaBuzz
ABOUT THIS PAGE
97
PharmaCompass offers a list of Quazepam API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Quazepam manufacturer or Quazepam supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Quazepam manufacturer or Quazepam supplier.
PharmaCompass also assists you with knowing the Quazepam API Price utilized in the formulation of products. Quazepam API Price is not always fixed or binding as the Quazepam Price is obtained through a variety of data sources. The Quazepam Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Quazapam manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Quazapam, including repackagers and relabelers. The FDA regulates Quazapam manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Quazapam API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Quazapam manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Quazapam supplier is an individual or a company that provides Quazapam active pharmaceutical ingredient (API) or Quazapam finished formulations upon request. The Quazapam suppliers may include Quazapam API manufacturers, exporters, distributors and traders.
click here to find a list of Quazapam suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Quazapam DMF (Drug Master File) is a document detailing the whole manufacturing process of Quazapam active pharmaceutical ingredient (API) in detail. Different forms of Quazapam DMFs exist exist since differing nations have different regulations, such as Quazapam USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Quazapam DMF submitted to regulatory agencies in the US is known as a USDMF. Quazapam USDMF includes data on Quazapam's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Quazapam USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Quazapam suppliers with USDMF on PharmaCompass.
The Pharmaceuticals and Medical Devices Agency (PMDA) established the Japan Drug Master File (JDMF), also known as the Master File (MF), to permit Japanese and foreign manufacturers of drug substances, intermediates, excipients, raw materials, and packaging materials (‘Products’) to voluntarily register confidential information about the production and management of their products in Japan.
The Quazapam Drug Master File in Japan (Quazapam JDMF) empowers Quazapam API manufacturers to present comprehensive information (e.g., production methods, data, etc.) to the review authority, i.e., PMDA (Pharmaceuticals & Medical Devices Agency).
PMDA reviews the Quazapam JDMF during the approval evaluation for pharmaceutical products. At the time of Quazapam JDMF registration, PMDA checks if the format is accurate, if the necessary items have been included (application), and if data has been attached.
click here to find a list of Quazapam suppliers with JDMF on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Quazapam as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Quazapam API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Quazapam as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Quazapam and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Quazapam NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Quazapam suppliers with NDC on PharmaCompass.
Quazapam Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Quazapam GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Quazapam GMP manufacturer or Quazapam GMP API supplier for your needs.
A Quazapam CoA (Certificate of Analysis) is a formal document that attests to Quazapam's compliance with Quazapam specifications and serves as a tool for batch-level quality control.
Quazapam CoA mostly includes findings from lab analyses of a specific batch. For each Quazapam CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Quazapam may be tested according to a variety of international standards, such as European Pharmacopoeia (Quazapam EP), Quazapam JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Quazapam USP).
